Morning Market Losers

Finisar FNSR shares tumbled 23.56% to $19.30 after the company reported downbeat earnings for the fourth quarter and issued a weak profit forecast for the current quarter. OncoMed Pharmaceuticals OMED dropped 20.64% to $19.76 after the company voluntarily stopped enrollment for Phase 1 Vantictumab. Cesca Therapeutics KOOL declined 16.39% to $1.48 after the company priced priced 7.53 million share offering at $1.55 per share. Oculus Innovative Sciences OCLS fell 7.29% to $3.05 on Q4 results. The company's net income rose $9.9 million to $7.5 million in the quarter. TG Therapeutics TGTX shares declined 7.26% to $8.18 after the company's TG-1101 in combination with Ibrutinib showed a 90% response rate in patients with previously treated CLL and MCL. Achillion Pharmaceuticals ACHN dropped 4.10% to $6.55 after dropping 6.32% on Thursday.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: NewsMovers & ShakersIntraday UpdateMarketsmarket losersTop Losers
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!